Global Blood Screening Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • Dec 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Blood Screening Market, By Products and Services (Reagents and Kits, Instruments, Software and Services), Technology (Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay, Rapid Tests, Western Blot Assay, Next-Generation Sequencing, Others), Disease Type (Respiratory Diseases, Diabetes Mellitus, Oncology, Cholesterol, HIV/AIDS, Cold and Flu, Infectious Diseases, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

 Blood Screening Market Market Analysis and Insights of Blood Screening Market

Blood screening market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 5.75% in the above-mentioned forecast period.

Blood screening is basically a medical test that is carried out on blood samples for diagnosis of various diseases such as hepatitis, syphilis, AIDS and other clinical conditions such as pregnancy. Moreover, it also assists in monitoring diseases and prevent health issues and a variety of other conditions such as infections and cancer. 

The rising occurrences of new form of pathogens and growing geriatric population are the significant factors responsible for driving the growth of the blood screening market. Additionally, the surging levels of investment for the development of advanced technology and favorable policies of the government regarding blood screening also heighten the overall growth of the market. However, the high costs involved in sampling of blood are estimated to obstruct the market’s growth.

The rising adoptions and acceptance rates from the consumers ever since the launch of instruments are expected to generate profitable opportunities for the market. On the other hand, the reusability of various instruments leveraged have the potential to challenge for the market’s growth.

This blood screening market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research blood screening market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Blood Screening Market Scope and Market Size

Blood screening market is segmented on the basis of products and services, technology, disease type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of products and services segment, the blood screening market is segmented into reagents and kits, instruments and software and services. Reagents and kits are further sub-segmented into NAT reagents and kits, ELISA reagents and kits others as well. NAT reagents is further sub-segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions also labelling and detection reagents. ELISA reagents and kits is further sub-segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) also sample diluents and wash solutions. Instruments segment is further segmented into instruments, product types and instruments and purchase type.
  • On the basis of technology, the blood screening market is segmented into nucleic acid test, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS) and others. Nucleic acid test is further sub-segmented into transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR). Enzyme-linked immunosorbent assay (ELISA) is further segmented into ELISA market, by platform, ELISA market, by generation. ELISA market, by platform is further sub-segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA) and colorimetric immunoassay (CI). ELISA market, by generation is further segmented into first-generation ELISA, second-generation ELISA, third-generation ELISA and fourth-generation and above.
  • On the basis of disease type segment, the blood screening market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold and flu, infectious diseases and others.
  • The end user segment in the blood screening market is segmented into diagnostic centers, blood bank, hospitals, clinics and ambulatory surgical centers.

 Blood Screening Market Country Level Analysis

Blood screening market is analyzed and market size insights and trends are provided by products and services, technology, disease type and end user as referenced above.

The countries covered in the blood screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to rising number of blood donations, and the high prevalence of novel pathogens, the presence of high-quality infrastructure across hospitals and clinical laboratories within the region. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the rising healthcare affordability, increased awareness regarding blood donations, and increased emphasis of major industry players on emerging and developing countries in the region.

The country section of the blood screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Blood screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for blood screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the blood screening market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Blood Screening Market Share Analysis

Blood screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to blood screening market.

Some of the major players operating in the blood screening market report are Enzo Biochem Inc., meridianbioscience., BD, Bio-Rad Laboratories, Inc., Thermo Fisher., BioMérieux SA, Beckman Coulter, Inc., Abbott, F. Hoffmann-La Roche Ltd, Cepheid, GENERAL ELECTRIC, Digirad Corporation., Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, GRIFOLS INTERNATIONAL, S.A., Siemens, Ortho Clinical Diagnostics, Immucor., and Hologic Inc., among others.

Customization Available : Global Blood Screening Marke

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Frequently Asked Questions